Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment

BACKGROUND: Allogeneic haematopoietic stem cell transplantation (allo-SCT) may provide donor cytotoxic T cell-/NK cell-mediated disease control in patients with rhabdomyosarcoma (RMS). However, little is known about the prevalence of graft-vs-RMS effects and only a few case experiences have been rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Thiel, U, Koscielniak, E, Blaeschke, F, Grunewald, T G P, Badoglio, M, Diaz, M A, Paillard, C, Prete, A, Ussowicz, M, Lang, P, Fagioli, F, Lutz, P, Ehninger, G, Schneider, P, Santucci, A, Bader, P, Gruhn, B, Faraci, M, Antunovic, P, Styczynski, J, Krüger, W H, Castagna, L, Rohrlich, P, Ouachée-Chardin, M, Salmon, A, Peters, C, Bregni, M, Burdach, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833217/
https://www.ncbi.nlm.nih.gov/pubmed/24149176
http://dx.doi.org/10.1038/bjc.2013.630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833217/
https://www.ncbi.nlm.nih.gov/pubmed/24149176
http://dx.doi.org/10.1038/bjc.2013.630

Ejemplares similares